Skip to main content
Caplight Logo









novaxomx

novaxomx

Private
FrankfurtHealthcare & Life Scienceshttps://novaxomx.com

Last Round

Joint Venture

Mar 21, 2022

Company Overview

novaxomx operates in Healthcare & Life Sciences and is based in Frankfurt. It was founded in 2022.

novaxomx is a biotechnology company that develops biosurgical therapies for musculoskeletal diseases and tissue regeneration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

novaxomx Comparables

Compare novaxomx with similar companies based on industry and business-model similarity.

novaxomx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Theradaptive
79%
Cerapedics
68%
RevBio, Inc.
63%
Book a demo to see all comparables

For institutional investors. Book with your work email.

novaxomx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Joint VentureMar 21, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

novaxomx Investors

Notable investors and investment history

novaxomx investors
InvestorRounds
Xlife Sciences AGJoint Venture

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Monthly visitors grew 155% MoM, from 118 to 301.

Book a demo to see all signals

For institutional investors. Book with your work email.

novaxomx Filings

Explore SEC and related filing metadata, where available.

novaxomx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about novaxomx's valuation, stock price, and market status.

Is novaxomx a public or private company?

novaxomx is a private company.

What is the current stock price of novaxomx?

novaxomx is a private company, so its shares have no public market price. Caplight tracks novaxomx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is novaxomx worth (valuation)?

Valuation information for novaxomx is not publicly available.

Can I buy novaxomx stock?

novaxomx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was novaxomx's last funding round?

novaxomx's most recent funding round was Joint Venture on March 21, 2022.

Who are the main investors in novaxomx?

Key investors in novaxomx include Xlife Sciences AG.

Will novaxomx IPO soon?

No public IPO plans have been announced for novaxomx.

How can I track novaxomx secondary market activity?

Caplight tracks bids, offers, and trades in novaxomx's shares on secondary markets.

Firmographic Details

HeadquartersFrankfurt
Year Founded2022
Last FundingMar 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?